In a study published in Advanced Functional Materials, a research team from the Shanghai Institute of Materia Medica (SIMM) ...
Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.
Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human trial.
More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.